Yüklüyor......
Interobserver Reproducibility of PD-L1 Biomarker in Non-small Cell Lung Cancer: A Multi-Institutional Study by 27 Pathologists
BACKGROUND: Assessment of programmed cell death-ligand 1 (PD-L1) immunohistochemical staining is used for treatment decisions in non-small cell lung cancer (NSCLC) regarding use of PD-L1/programmed cell death protein 1 (PD-1) immunotherapy. The reliability of the PD-L1 22C3 pharmDx assay is critical...
Kaydedildi:
| Yayımlandı: | J Pathol Transl Med |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6877442/ https://ncbi.nlm.nih.gov/pubmed/31656061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4132/jptm.2019.09.29 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|